Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 5Unknown 2Terminated 2Active not recruiting 2Recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 25Thoracic 9Head & Neck 7CNS 7Breast 7Sarcoma 6Genitourinary 5Gynecologic 4Dermatologic 3Endocrine 2Other 1

Conditions

Pheochromocytoma 1Multiple Endocrine Neoplasia Type 1 1Infertility 1Adrenal Gland Neoplasms 1

Interventions

Everolimus 10lanreotide 4Capecitabine 4pasireotide 3lutetium Lu 177 dotatate 3lenvatinib 3fosbretabulin 3Temozolomide 3Sorafenib 3Paclitaxel 3Octreotide 3Nivolumab 3Magnetic Resonance Spectroscopy 3Filgrastim 3Erlotinib Hydrochloride 3Doxorubicin 3trifluridine tipiracil drug combination 2surufatinib 2pembrolizumab 2pegfilgrastim 2gallium Ga 68 dotatate 2durvalumab 2dactolisib 2Surveys and Questionnaires 2Surgical Procedures, Operative 2Sunitinib 2Rosiglitazone 2Radiotherapy 2Panobinostat 2Mitotane 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Surgical Procedures, Operative × Endocrine × Clear all
NCT01348698 2018-11-26

Evaluation of Molecular Markers in Adrenal Tumors

National Institutes of Health Clinical Center (CC)

Terminated
74 enrolled 10 charts
Endocrine

Adrenal Gland Neoplasms, Pheochromocytoma

NCT00767338 2013-07-02

VIA

Yale University

Phase 3 Terminated
3 enrolled 3 charts
Endocrine

Infertility, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡